BCL2 and neoplasm: When tested in in vivo studies, the combination of CBD (5 mg/kg) and DOX reduced tumor volume (p < 0.001, n = 4), increased the expression of BAX and cleaved caspase-3, and decreased Bcl2 and mTOR [34].